In SCLC, the purine synthesis pathway through phosphoribosyl pyrophosphate amidotransferase (PPAT) is favored over the citric acid cycle through glutaminase (GLS), potentially due to MYC since PPAT is one of its target genes [205]. This evidence concerns the gene PPAT and small cell lung carcinoma.